However, in this study, the authors indicated that GR was not an independent predictor of survival, and no association was found between GR expression and breast cancer-specific survival (BCSS) or distant metastasis-free interval (DMFI) in the whole series or the ER-positive group [14]. This evidence concerns the gene NR3C1 and breast carcinoma.